MobiHealthNews

FDA panel advises agency to greenlight Dexcom G5 CGM as replacement to fingerstick treatment decisions

An FDA advisory panel has voted in favor of recommending a change to the intended use of Dexcom’s G5 Continuous Glucose Monitor (CGM). The G5 had already been FDA-approved, but with limitations as an ...
Monthly Prescribing Reference

FDA: Dexcom G5 CGM System Can Replace Fingerstick Testing in T2DM Management

The Food and Drug Administration (FDA) has expanded the use of Dexcom's G5 Mobile Continuous Glucose Monitoring (CGM) System to allow for replacement of blood glucose testing for diabetes treatment ...
MobiHealthNews

FDA meeting to weigh whether Dexcom's G5 CGM can replace fingersticks for treatment decisions

Next month the FDA is hosting a public advisory committee meeting to discuss a change to the intended use of Dexcom's G5 Mobile Continuous Glucose Monitoring System (CGM) device that would allow the ...
Healio

FDA approves DexCom CGM system to replace fingerstick testing

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved an expanded indication for DexCom’s G5 Mobile Continuous Glucose Monitoring System to ...